370 related articles for article (PubMed ID: 36044600)
1. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
[No Abstract] [Full Text] [Related]
2. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
[TBL] [Abstract][Full Text] [Related]
3. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.
Schieber LZ; Dunphy C; Schieber RA; Lopes-Cardozo B; Moonesinghe R; Guy GP
JAMA Psychiatry; 2023 Apr; 80(4):331-341. PubMed ID: 36790774
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits - United States, April 2020-December 2020.
Board AR; Kim S; Park J; Schieber L; Miller GF; Pike J; Cremer LJ; Asher A
Drug Alcohol Depend; 2022 Mar; 232():109297. PubMed ID: 35033956
[TBL] [Abstract][Full Text] [Related]
6. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
7. Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records.
Tuan WJ; Kindt HM; Lennon RP
BMJ Open; 2023 Dec; 13(12):e074993. PubMed ID: 38072495
[TBL] [Abstract][Full Text] [Related]
8. Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality.
Christian N; Zhou X; Radhakrishnan R
medRxiv; 2023 Nov; ():. PubMed ID: 38077025
[TBL] [Abstract][Full Text] [Related]
9. Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids).
Shmulewitz D; Stohl M; Greenstein E; Roncone S; Walsh C; Aharonovich E; Wall MM; Hasin DS
Psychol Med; 2023 Apr; 53(5):1955-1969. PubMed ID: 35506791
[TBL] [Abstract][Full Text] [Related]
10. HIV Prevalence and HIV Screening History Among a Veterans Association Cohort of People with Opioid and Alcohol Use Disorders.
McCann NC; Davenport MJ; Mandavia AD; Stein MD; Livingston NA
J Gen Intern Med; 2024 Feb; 39(3):403-410. PubMed ID: 37848765
[TBL] [Abstract][Full Text] [Related]
11. Trends in substance use disorder diagnoses among Veterans, 2009-2019.
Hoggatt KJ; Chawla N; Washington DL; Yano EM
Am J Addict; 2023 Jul; 32(4):393-401. PubMed ID: 36883297
[TBL] [Abstract][Full Text] [Related]
12. Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic.
Meshberg-Cohen S; Farook M; Gross G; Levina V; DeViva J
Am J Addict; 2023 Jan; 32(1):32-39. PubMed ID: 36286598
[TBL] [Abstract][Full Text] [Related]
13. Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults.
Harton MR; Adams ZW; Parker MA
Exp Clin Psychopharmacol; 2023 Dec; 31(6):998-1004. PubMed ID: 37166911
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
Wang QQ; Kaelber DC; Xu R; Volkow ND
Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
[TBL] [Abstract][Full Text] [Related]
15. Comparing COVID-19-related Morbidity and Mortality Between Patients With and Without Substance Use Disorders: A Retrospective Cohort Study.
McLaughlin A; Burns R; Ryan M; Abbasi W; Harvey L; Hicks J; Sinha P; Assoumou SA
Subst Abuse; 2023; 17():11782218231160014. PubMed ID: 36968974
[TBL] [Abstract][Full Text] [Related]
16. Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019.
Lesko CR; Falade-Nwulia OO; Pytell JD; Hutton HE; Fojo AT; Keruly JC; Moore RD; Chander G
Addiction; 2023 Nov; 118(11):2193-2202. PubMed ID: 37491566
[TBL] [Abstract][Full Text] [Related]
17. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021.
Wang L; Wang Q; Davis PB; Volkow ND; Xu R
World Psychiatry; 2022 Feb; 21(1):124-132. PubMed ID: 34612005
[TBL] [Abstract][Full Text] [Related]
18. Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study.
Ellis JD; Rabinowitz JA; Ware OD; Wells J; Dunn KE; Huhn AS
J Subst Use Addict Treat; 2023 Mar; 146():208932. PubMed ID: 36880895
[TBL] [Abstract][Full Text] [Related]
19. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
[TBL] [Abstract][Full Text] [Related]
20. High Risk of Alcohol-Impaired Driving in Adults With Comorbid Alcohol and Substance Use Disorders in the U.S. Population.
Roberts W; Moore KE; Pittman BP; Fillmore MT; McKee SA
J Stud Alcohol Drugs; 2019 Jan; 80(1):114-119. PubMed ID: 30807283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
